

Two Onc Docs
Sam and Karine
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*
Episodes
Mentioned books

Oct 16, 2023 • 14min
Breast Cancer Screening, Prevention & Intro 2023 UPDATE
This podcast provides high yield tips on breast cancer screening, prevention, and introduces non-invasive breast pathologies. It also discusses treatment options, including surgical procedures and lymph node staging. Key takeaways include screening recommendations, prevention strategies, and risk factors for breast cancer.

Oct 2, 2023 • 10min
Heparin Induced Thrombocytopenia
This podcast explores heparin induced thrombocytopenia, including its pathophysiology, diagnosis, and treatment. Topics include ruling out pseudo thrombocytopenia, understanding the role of heparin and Platelet Factor Four, diagnosing HIT using clinical criteria and additional testing methods, and the use of direct thrombin inhibitors for anticoagulation.

Sep 25, 2023 • 18min
Stem Cell Transplantation
The podcast covers the different types of stem cell transplant, conditioning regimens, and complications. It discusses the use of stem cell transplantation in cancer treatment and finding donors for allogenic stem cell transplant. The importance of umbilical transplant and conditioning regimens is also highlighted. It further explores graft-versus-host disease and various complications that can occur in stem cell transplant patients.

Sep 18, 2023 • 16min
Metastatic Prostate Cancer 2023 UPDATE
Exploring cutting-edge therapies for metastatic prostate cancer including triplet and doublet therapies, radium-223, Lutetium-LU-177 targeted therapy, and genetic testing significance with Drimline testing standards. Also, discussing the importance of supportive care, dental clearance, and monitoring PSA levels for personalized treatment protocols in 2023.

Sep 11, 2023 • 16min
Localized Prostate Cancer 2023 UPDATE
Exploring updates on localized prostate cancer in 2023, including advancements in detection with PSMA PET scans and treatment options based on risk levels. Covering the importance of PSA testing, staging, grading, and understanding treatment approaches for positive lymph nodes.

Aug 28, 2023 • 19min
Metastatic Colon Cancer 2023 UPDATE
This 2023 update on metastatic colon cancer discusses molecular studies, treatment options, and toxicities of Full Fox and Full Theory regimens. It also explores genetic biomarkers, targeted therapies, and treatment approaches for oligometastatic colon cancer.

Aug 21, 2023 • 18min
Localized Colon Cancer 2023 UPDATE
Update on early stage colon cancer, risk factors, hereditary syndromes, staging importance, adjuvant chemotherapy options post-surgery, circulating tumor DNA role in treatment decisions, and detailed follow-up protocols.

Aug 14, 2023 • 19min
Acquired Hemolytic Anemias
This podcast discusses acquired forms of hemolytic anemia, such as warm autoimmune hemolytic anemia, cold agglutinin disease, and paroxysmal cold hemoglobinuria. They explore various types of hemolytic anemia, treatment options, key toxicities of monoclonal antibodies, and important takeaways for distinguishing and treating different types of hemolytic anemia.

Aug 7, 2023 • 14min
Inherited Platelet Disorders
This week’s episode will be focusing on inherited platelet disorders. We will go over the important details on the roles of platelets, the diagnosis of inherited platelet disorders through aggregation studies, as well as the treatment of these disorders.

Jul 31, 2023 • 11min
Primary Myelofibrosis
Discussion on primary myelofibrosis (PMF) and other myeloproliferative neoplasms, including diagnosis, risk stratification, treatment options. Topics include extra-medular hematopoiesis, diagnostic criteria, staging, risk factors, molecular risk, prognosis, supportive care, medication options, stem cell transplant.


